S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
AI Stock Caught Trading Under Secret Name (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Laser breakthrough could send stock soaring 2,467% (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Laser breakthrough could send stock soaring 2,467% (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
What recession? Professional forecasters raise expectations for US economy in 2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
AI Stock Caught Trading Under Secret Name (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Laser breakthrough could send stock soaring 2,467% (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Laser breakthrough could send stock soaring 2,467% (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
What recession? Professional forecasters raise expectations for US economy in 2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
AI Stock Caught Trading Under Secret Name (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Laser breakthrough could send stock soaring 2,467% (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Laser breakthrough could send stock soaring 2,467% (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
What recession? Professional forecasters raise expectations for US economy in 2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
AI Stock Caught Trading Under Secret Name (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Laser breakthrough could send stock soaring 2,467% (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Laser breakthrough could send stock soaring 2,467% (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
What recession? Professional forecasters raise expectations for US economy in 2024
NASDAQ:LNTH

Lantheus (LNTH) Stock Price, News & Analysis

$66.27
+1.22 (+1.88%)
(As of 02/23/2024 ET)
Today's Range
$65.00
$66.60
50-Day Range
$51.07
$66.27
52-Week Range
$50.20
$100.85
Volume
1.23 million shs
Average Volume
916,956 shs
Market Capitalization
$4.54 billion
P/E Ratio
14.28
Dividend Yield
N/A
Price Target
$108.14

Lantheus MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
63.2% Upside
$108.14 Price Target
Short Interest
Healthy
7.29% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.67
Upright™ Environmental Score
News Sentiment
0.68mentions of Lantheus in the last 14 days
Based on 32 Articles This Week
Insider Trading
Selling Shares
$37,960 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.93 out of 5 stars

Medical Sector

20th out of 936 stocks

Diagnostic Substances Industry

1st out of 13 stocks


LNTH stock logo

About Lantheus Stock (NASDAQ:LNTH)

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; and Cardiolite, an injectable Tc-99m-labeled imaging agent. The company also offers AZEDRA, a radiotherapeutic therapy; Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; PNT2002 for pre-chemotherapy patients; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; and PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer. The company serves hospitals, independent diagnostic testing facilities, government facilities, integrated delivery networks, radiopharmacies, clinics, distirbutors, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; and FUJIFILM. The company was founded in 1956 and is based in Bedford, Massachusetts.

LNTH Stock Price History

LNTH Stock News Headlines

Disturbing Truth About Biden's New Program To Seize Your Cash
A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
LNTH Apr 2024 110.000 call
Assessing Lantheus Holdings: Insights From 4 Financial Analysts
LNTH Mar 2024 30.000 put
Elon Musk's "Project Dojo" is a Game-Changer
Morgan Stanley predicts that Musk's latest act will boost Tesla's shares by 80% in the next 12 months. But if you want to profit from this development, you'll buy the firm that could see its sales explode by 829% as "Project Dojo" sweeps the nation.
Lantheus Holdings Gains On Announcement Of Upbeat Q4 Report
Lantheus Holdings, Inc. (LNTH)
Lantheus Q4 2023 Earnings Preview
Lantheus (LNTH) Set to Announce Quarterly Earnings on Thursday
LNTH Feb 2024 80.000 call
See More Headlines
Receive LNTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lantheus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
2/25/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic substances
Sub-Industry
N/A
Current Symbol
NASDAQ:LNTH
Employees
698
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$108.14
High Stock Price Target
$127.00
Low Stock Price Target
$95.00
Potential Upside/Downside
+63.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Net Income
$28.07 million
Pretax Margin
31.70%

Debt

Sales & Book Value

Annual Sales
$1.30 billion
Cash Flow
$4.73 per share
Book Value
$11.91 per share

Miscellaneous

Free Float
67,462,000
Market Cap
$4.54 billion
Optionable
Optionable
Beta
0.53
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report














LNTH Stock Analysis - Frequently Asked Questions

Should I buy or sell Lantheus stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lantheus in the last twelve months. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" LNTH shares.
View LNTH analyst ratings
or view top-rated stocks.

What is Lantheus' stock price target for 2024?

7 Wall Street analysts have issued 12-month target prices for Lantheus' stock. Their LNTH share price targets range from $95.00 to $127.00. On average, they expect the company's share price to reach $108.14 in the next year. This suggests a possible upside of 63.2% from the stock's current price.
View analysts price targets for LNTH
or view top-rated stocks among Wall Street analysts.

How have LNTH shares performed in 2024?

Lantheus' stock was trading at $62.00 at the beginning of the year. Since then, LNTH stock has increased by 6.9% and is now trading at $66.27.
View the best growth stocks for 2024 here
.

Are investors shorting Lantheus?

Lantheus saw a drop in short interest during the month of January. As of January 31st, there was short interest totaling 4,890,000 shares, a drop of 11.4% from the January 15th total of 5,520,000 shares. Based on an average trading volume of 1,300,000 shares, the short-interest ratio is currently 3.8 days. Approximately 7.3% of the shares of the company are short sold.
View Lantheus' Short Interest
.

When is Lantheus' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our LNTH earnings forecast
.

How were Lantheus' earnings last quarter?

Lantheus Holdings, Inc. (NASDAQ:LNTH) released its quarterly earnings results on Thursday, November, 4th. The medical equipment provider reported $0.08 earnings per share for the quarter, topping analysts' consensus estimates of $0.06 by $0.02. The medical equipment provider had revenue of $102.10 million for the quarter, compared to the consensus estimate of $97.13 million. Lantheus had a trailing twelve-month return on equity of 63.16% and a net margin of 25.20%. The company's revenue was up 15.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.04 EPS.

What guidance has Lantheus issued on next quarter's earnings?

Lantheus issued an update on its first quarter 2024 earnings guidance on Thursday, February, 22nd. The company provided earnings per share (EPS) guidance of 1.500-1.540 for the period, compared to the consensus EPS estimate of 1.510. The company issued revenue guidance of $347.0 million-$355.0 million, compared to the consensus revenue estimate of $336.4 million.

What is Mary Anne Heino's approval rating as Lantheus' CEO?

4 employees have rated Lantheus Chief Executive Officer Mary Anne Heino on Glassdoor.com. Mary Anne Heino has an approval rating of 51% among the company's employees. This puts Mary Anne Heino in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Lantheus own?
When did Lantheus IPO?

(LNTH) raised $75 million in an initial public offering (IPO) on Thursday, June 25th 2015. The company issued 7,900,000 shares at a price of $8.50-$10.50 per share. Citigroup, Jefferies, RBC Capital Markets and Wells Fargo Securities acted as the underwriters for the IPO and Baird was co-manager.

Who are Lantheus' major shareholders?

Lantheus' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (10.18%), Price T Rowe Associates Inc. MD (2.39%), Price T Rowe Associates Inc. MD (2.39%), Westfield Capital Management Co. LP (2.28%), Reinhart Partners LLC. (1.98%) and Dimensional Fund Advisors LP (1.67%). Insiders that own company stock include Andrea Sabens, Brian A Markison, Carol Walker, Daniel Niedzwiecki, Etienne Montagut, Gerard Ber, Heinz Christoph Maeusli, John J Bolla, Mary Anne Heino, Michael P Duffy, Michael P Duffy, Minnie Baylor-Henry, Paul Blanchfield, Robert J Jr Marshall and Sam R Leno.
View institutional ownership trends
.

How do I buy shares of Lantheus?

Shares of LNTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LNTH) was last updated on 2/25/2024 by MarketBeat.com Staff